IntroductionTransarterial chemoembolization (TACE) is inefficient at converting unresectable hepatocellular carcinoma (uHCC) to resectable. Treatment with immune checkpoint inhibitors (ICIs) is an emerging strategy for uHCC. Combined therapy of TACE with ICIs is considered to improve the therapeutic effect. https://www.jmannino.com/quick-save-Canon-imageCLASS-MF227dw-Monochrome-Multifunction-Laser-Printer-great-choice/